Detalles de la búsqueda
1.
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 21(12): 3019-3029.e5, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37061107
2.
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Gastroenterology
; 163(4): 937-949.e2, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35753383
3.
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
Rheumatol Int
; 41(9): 1657-1665, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944985
4.
Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis.
Arthritis Rheum
; 63(3): 662-9, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21360495
5.
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.
Arthritis Rheumatol
; 74(8): 1321-1332, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507355
6.
Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis.
Ann Rheum Dis
; 70(8): 1461-4, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21666230
7.
Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs.
Ann Rheum Dis
; 69(5): 845-50, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20233753
8.
The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.
Ann Rheum Dis
; 69(6): 1110-6, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20439289
9.
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
Trials
; 21(1): 13, 2020 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907007
10.
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases.
Arthritis Rheumatol
; 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37984460
11.
FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression.
J Rheumatol
; 38(11): 2329-35, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21885492
12.
Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.
Arthritis Res Ther
; 11(4): R103, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19570223
13.
Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
J Rheumatol
; 36(2): 266-72, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19132792
14.
Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
J Rheumatol
; 36(8): 1769-84, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19671812
15.
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria.
J Rheumatol
; 36(8): 1785-91, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19671813
16.
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
J Rheumatol
; 36(8): 1792-9, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19671814
17.
A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients.
Arthritis Res Ther
; 10(2): R28, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18312691
18.
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
J Rheumatol
; 34(3): 623-33, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17343310
Resultados
1 -
18
de 18
1
Próxima >
>>